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SUMMARY 23 
 Given the importance of Avian avulaviruses (AAvVs) in commercial poultry, 24 
continuous monitoring and surveillance in natural reservoirs (waterfowls) is imperative. Here, 25 
we report full genomic and biological characterization of two virulent AAvVs isolated from 26 
apparently asymptomatic Green-winged teal (Anas carolinensis). Genetic characterization 27 
[(genome length, coding potential and presence of typical cleave motif (112RRQKR↓F117)] and 28 
biological assessment (HA: log29, mean death time: 49.2-50 hrs, 10-6.51 EID50/0.1mL and 1.5 29 
Intracerebral pathogenicity index or ICPI value) revealed virulence of both isolates. 30 
Phylogenetic analysis of complete genome and hypervariable region of the fusion (F) gene 31 
revealed clustering of both isolates within class-II strains in close-association with domestic 32 
poultry-origin AAvVs representing genotype VII and sub-genotype VIIi. The inferred residue 33 
analysis of F and haemagglutinin-neuraminidase genes showed a number of substitutions in 34 
critical domains compared to reference strains of each genotype (I-XVIII). The isolates showed 35 
a high nucleotide resemblance (99%) with strain isolated previously from backyard poultry, 36 
however showed a variable similarity (16.1% to 19.3%) with most commonly used vaccine 37 
strains; Mukteswar (EF201805) and LaSota (AF077761). In accordance to pathogenicity 38 
assessment and horizontal transmission, the clinical and histopathological observations in 39 
experimental chicken indicated velogenic viscerotropic nature of AAvV 1 isolates. Taken 40 
together, study concludes evolutionary nature of AAvVs and their potential role in disease 41 
occurrence, necessitating continuous surveillance of migratory/aquatic fowls to better elucidate 42 
infection epidemiology and potential impacts on commercial poultry. 43 
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Abbreviation: AAvVs = Avian avulaviruses; AAvV 1= Avian avulavirus 1; HA= 46 
Haemagglutination assay; ICPI= Intra-cerebral pathogenicity index; MDT= Mean death time; 47 
  
EID50= Embryo infective dose; ND= Newcastle disease; F= Fusion; HN= Haemagglutinin-48 
neuraminidase; KPK= Khyber Pakhtun Khwa; HI= Haemagglutination inhibition; RT-PCR= 49 
Reverse transcriptase polymerase chain reaction; NCBI= National centre for biotechnology 50 
information; ORF= Open reading frame; HR= Hydrophobic heptad repeat region; GARD= 51 
Genetic algorithm for recombination detection. 52 
INTRODUCTION 53 
Avian avulaviruses (AAvVs) are enveloped, mono-partite, negative sense and single-stranded 54 
RNA viruses, and are classified into the genus Avulavirus and family Paramyxoviridae (6). 55 
Newcastle disease (ND), caused by Avian Avulavirus 1 (previously known as avian 56 
paramyxovirus 1), is a highly contagious disease of multiple avian species including 57 
commercial poultry, and are posing significant economic impacts worldwide (5). The whole 58 
genome of AAvV-1 is either 15186, 15192 or 15198 nucleotides in length and encodes six 59 
structural proteins in an order of 3ʹ-NP-P-M-F-HN-L-5ʹ (5, 26). Based on the pathogenicity, 60 
AAvV 1 are categorized into velogenic, mesogenic, lentogenic or avirulent (8). The presence 61 
of mono- or poly-basic amino acids in fusion (F) protein is considered a key determinant of 62 
virulence (13). Based on clustering patterns, all AAvV 1 strains can be classified into two 63 
classes within a single serotype; Class-I contains at least nine genotypes of avirulent AAvVs 64 
and Class-II consists of at least eighteen genotypes of virulent AAvVs (15). Based on partial 65 
sequence of the F gene (375bp between 4597-4972 nts), genotypes VI and VII can be further 66 
classified into eight (a-h) and eleven (a–k) further sub-genotypes, respectively (17, 32-34, 36, 67 
49), which depict a high level of genetic heterogeneity and distribution of multiple strains of 68 
AAvVs in the environment (22, 41, 66). 69 
 Being a natural reservoir for AAvVs, aquatic and/or wild waterfowls have potential to 70 
shed virus in the environment for an extended period of time and, therefore, could be potential 71 
sources of disease transmission to highly susceptible and commercially valuable hosts such as 72 
  
chickens (49). Virulent AAvVs have previously been reported from clinically healthy green-73 
winged teal (39, 44); nevertheless, there is a paucity of higher resolution characterization of 74 
genome, evolutionary dynamics and occurrence of potential recombination events across the 75 
length of viral genome. While aquatic bird-origin AAvV strains are reported, the 76 
characterization is mainly attributed to partial sequencing of hypervariable region of F gene 77 
(24, 25, 27). Additionally, biological assessments of AAvVs isolated from teal have not been 78 
assessed before. Therefore, owing to proven roles in virus transmission and potential threats to 79 
commercial vulnerable poultry, it is imperative to investigate the evolutionary and infectious 80 
potential of these viruses from waterfowl. In this study, we determined genetic and biologic 81 
assessments of two AAvVs isolated from clinically healthy green-winged teal from Pakistan.  82 
MATERIALS AND METHODS 83 
Ethics statement 84 
 This study was carried out in strict accordance with the recommendations of the Guide 85 
for the Care and Use of Laboratory Animals by National Institutes of Health and Animal 86 
Research Council (https://grants.nih.gov/grants/olaw/guide-for-the-care-and-use-of-87 
laboratory-animals.pdf). The swab sampling, embryonated eggs inoculation and other essential 88 
protocols were approved by the Ethical Review Committee for the Use of Laboratory Animals 89 
(ERCULA) of University of Veterinary and Animal Sciences, Lahore vide permit number 90 
ORIC/DR-70 dated March 15, 2015. 91 
Sample collection and virus isolation 92 
 During 2015-2016, a total of 217 Green-winged teal (Anas carolinensis) were captured 93 
with mist-net during an avian influenza surveillance program at Chashma Barrage, Pakistan 94 
(60). The barrage (32º 25´ N, 71º 22´ E) is built on the River Indus and serves as one of the 95 
major wildlife sanctuary for aquatic and terrestrial habitat under the provision of Punjab 96 
Wildlife Act, 1974. Precisely, comprised of 0.327 Mha, it is located in the provinces of Punjab 97 
  
and Khyber Pakhtun Khwa (KPK), Pakistan. Major part of sanctuary lies in the Punjab 98 
province (district Mianwali) while a small proportion lies in Tehsil Lakki Marwat of Dera 99 
Ismail Khan District in KPK province. The barrage is considered as a wetland of international 100 
importance that accommodates a large variety of migratory and indigenous birds each year (2). 101 
Cloacal and oropharyngeal swabs were collected from clinically healthy teals and transferred 102 
to laboratory as described by Halverson et al. (21). Each sample was prepared and processed 103 
for the isolation of virus using 9-day-old embryonated chicken eggs following standard 104 
protocol (52). Harvested fluid was confirmed as AAvV 1 by F gene-based PCR (49, 66) 105 
followed by spot hemagglutination (HA) assays (52). The AAvV 1 confirmed isolates were 106 
stored at -80oC until used.  107 
Biological characterization of isolates 108 
 Hemagglutination inhibition (HI) test with antisera against AAvV 1 was performed for 109 
both isolates according to standard protocol (52). The pathogenicity of each isolate was 110 
assessed through egg infectious dose 50 (EID50 ml
-1) by inoculating into 9-11-day old 111 
embryonated chicken eggs as described by Reed and Muench (43). Intra-cerebral pathogenicity 112 
index (ICPI) tests in one-day-old chicken and the mean death time (MDT) in 9-day-old 113 
embryonated chicken eggs were determined following previously described procedures (52). 114 
Complete genome sequencing of isolates 115 
 Extraction of viral RNA from harvested allantoic fluid was performed using QIAamp 116 
Viral RNA extraction Mini Kit as per manufacturer’s instructions (Qiagen, Valencia city, CA, 117 
USA). The whole genome was amplified by one-step Reverse Transcriptase Polymerase Chain 118 
Reaction (RT-PCR) using our previously reported primers and protocols (35). The amplified 119 
PCR products were purified using the Wizard® SV Gel and PCR Clean-Up System as 120 
recommended by manufacturer (Promega, Co., Madison, WI, USA). Amplicons were 121 
  
sequenced in both directions with primers used for amplification through ABI PRISM Genetic 122 
Analyzer 3130x1 version (Applied Biosystems, Foster City, CA, USA). 123 
Phylogenetic and amino acid residue analysis 124 
 Complete nucleotide sequence of each isolate was assembled using Geneious® version 125 
8.1.6 (16). The obtained sequences were compared to GenBank database using BLAST tool at 126 
NCBI (https://blast.ncbi.nlm.nih.gov/Blast.cgi). Assembled sequence of each isolate was 127 
aligned with strains representing different genotypes (GenBank) using ClustalW methods in 128 
BioEdit® version 5.0.6 (20) for subsequent phylogeny, prediction of deduced amino acid 129 
substitution sites for the F and HN genes, and for nucleotide and amino acid similarity indices. 130 
To determine sub-genotype, the hypervariable region of the F gene of both isolates was 131 
analysed in comparison with previously reported AAvVs around the globe 132 
(http://www.ncbi.nlm.nih.gov/) using distance-based neighbour-joining  method (1000 133 
replication bootstrap values)in MEGA® version 6.0 software (54). Nucleotide identity among 134 
whole genome and individual protein was determined using ORF of selected strains of all 135 
genotypes (I-XVIII); Pairwise Sequence Comparisons (PASC) analysis was performed using 136 
MEGA software. The complete F and HN amino acid sequences were submitted to I-TASSER® 137 
(https://zhanglab.ccmb.med.umich.edu/I-TASSER/) for 3-dimensional structural analysis of 138 
each protein (63). Substitutions of amino acid in the F and HN proteins were annotated through 139 
PyMol® software (https://www.pymol.org/). 140 
Recombination Analysis 141 
 To estimate the inter- and intra-class recombination of under-study isolates, complete 142 
genome sequence of representative strains of each genotype (GenBank database) was subjected 143 
to SimPlot Version 3.5.1 (42), GARD (48) and RDP version 4.70 (28). Distance-based 144 
similarity method in SimPlot allowed percentage identity of query sequence to a panel of 145 
reference sequences. BootScan analysis, maximum χ2 method (implementing GARD online, 146 
  
http://www.datamonkey.org/GARD) and RDP were used to assess likelihood of a locus for 147 
recombination events and putative breakpoint within genotype of both isolates. Utilizing 148 
several recombination detection methods into single suite of tool, the RDP package is 149 
considered a fast, simple and sensitive method for identification of putative recombination 150 
breakpoints (29). 151 
Accession Numbers 152 
 Complete nucleotide sequences of both isolates were submitted to GenBank database 153 
and are available under accession numbers MF437286 (Anas carolinensis-I-UVAS-Pak-2015) 154 
and MF437287 (Anas carolinensis-II-UVAS-Pak-2015). 155 
Experimental challenge and transmission in chickens 156 
A total of 20 clinical healthy chickens were used in the present study to assess the patho-typing 157 
of isolates based on the clinical presentation of infection, gross lesions and histopathology. All 158 
chickens were screened negative for avian influenza virus (AIV) and AAvV 1-specific HI 159 
antibodies in blood, and antigen in naso-oral and cloacal swabs samples using ELISA and RT-160 
PCR, respectively. These 27-day-old chickens (n=20) were randomly divided into three groups 161 
[Group 1 had 10 birds (challenged chickens), Group 2 had 5 birds (contact chickens) and Group 162 
3 had 5 birds (mock or negative control chickens)]. The challenge group of chickens was 163 
inoculated with 0.1 mL 10-6.51 EID50 of Anas carolinensis-I-UVAS-Pak-2015 isolate bilaterally 164 
via intranasal route. The control group was inoculated with 0.2 mL phosphate-buffered saline 165 
(PBS). After 24 hrs of infection, the contact chickens were kept together with virus-challenged 166 
chickens for the assessment of possible horizontal transmission of virus. All chickens were 167 
housed in separate negative pressure isolators and were provided food and water ad libitum. 168 
All chickens were clinically monitored every day for clinical presentation of the ND. With the 169 
onset of infection evidenced by observation of clinical signs, infected chicken was sacrificed 170 
and tissue samples (lung, liver, spleen, brain, bursa and small intestine) were collected in 10% 171 
  
neutral buffered formalin for fixation and hematoxylin and eosin staining for subsequent 172 
histopathological observations. 173 
RESULTS  174 
Biological assessment of the two AAvV 1 isolates 175 
 Alongside influenza surveillance, genome corresponding to avian avulavirus was 176 
detected in 19 independently harvested allantoic fluid (8.76%) of teals. Since isolates were 177 
obtained during one-time surveillance programme and were detected in the same flock, we 178 
processed only two of randomly selected isolates for further biological and molecular 179 
characterization. Hemagglutination assay on both isolates showed a high titre (log29/50ul) and 180 
revealed a high positive inhibition of haemagglutination (HI titre) with AAvV 1-specific 181 
antisera. The ICPI value for both isolates was found to be 1.5. The mean embryo infective 182 
doses (EID50) for isolates were 10
-6.51 and 10-6.53, respectively. A general description of each 183 
isolate along with various studied parameters is provided in Table 1. 184 
Phylogenetic and evolutionary analysis 185 
 Full-length genome sequences of both isolates showed similar length (15,192 nts), 186 
followed the “rule of six” and genes in an order of 3ʹ-NP-P-M-F-HN-L-5ʹ (Table 2). 187 
Phylogenetic analysis of whole genome (Fig. 1A), HN (Fig. 1B) and F genes (Fig. 1C), 188 
clustered both isolates within genotype VII, closely related to previously reported isolates from 189 
layer chicken (KX791185-87) and duck (KU845252) in Pakistan and vaccinated commercial 190 
broiler chicken (HQ697254) from Indonesia. Phylogenetic analysis of hyper-variable region 191 
grouped both isolates within sub-genotype VIIi with a close relationship to isolates reported 192 
previously from backyard poultry and wild birds in different regions of Pakistan (Fig. 1D). 193 
Nucleotide divergence indices of study isolates revealed a minimum difference (1%) for 194 
genotype VII. Based on coding regions of both isolates, HN gene showed a low nucleotide 195 
percentage divergence (0.7%) with genotype VII followed by L gene (0.7%), NP gene (0.6-196 
  
0.9%), F gene (1.1%), M gene (1.3%) and P gene (1.4%). Added to this, percentage nucleotide 197 
divergence to vaccine strains were observed to be 16.1% and 19.3% for Mukteswer and LaSota, 198 
respectively (Table 2). 199 
Residue analysis of F and HN proteins 200 
  The predicted residue analysis of F protein revealed a typical proteolytic cleavage 201 
motif of RRQKR↓F for residues between positions 112-117. Several neutralising sites (D72, 202 
E74, A75, K78, A79, and L343) across a stretch of residues between 156-171 aa, six glycosylation 203 
sites (85N-R-T87, 191N-N-T193, 366N-T-S368, 447N-I-S449, 471N-N-S473 and 541N-N-T543) and 204 
twelve cysteine residues were conserved in the putative F protein. However, a single 205 
substitution in signal peptide (1-31 aa, Y20C) and two substitutions in fusion peptide (117-142 206 
aa, V121I, I125V) were noticed. Hydrophobic heptad repeats (HR) regions showed one 207 
substitution, each in HRa region (143-185 aa, S171A), HRb region (268-29 aa, Y272N) and 208 
HRc region (471-500 aa, R494K). Three substitutions were found in major trans-membrane 209 
domain (501-521 aa, V506A, L512I and V521G). Substitutions at 52, 107 and 445 residue 210 
position were exclusive in non-conserved regions of studied isolates (Fig. 2).  211 
  The HN gene comprised of a single ORF encoding 571 amino acids.  A total of 13-212 
cysteine residues and four glycosylation sites (119N-N-S121, 433N-K-T435, 481N-H-T483 and 538N-213 
K-T540) were observed in both isolates. However, four substitutions (M33T, I34V, M35V/I, 214 
I36T) in transmembrane domain (25-45 aa), two (S77N, I81V) in HRa region (74-88 aa) and 215 
one (N569D) at site 2 were observed. No significant substitution was found in site 23, P1, site 216 
1 and 14, P2, P3, HRc domain and site 2 and 12. Five substitutions at 58, 218, 308, 387 and 217 
431were exclusive in studied isolates (Fig. 3).  218 
 Because both isolates shared a high percentage of nucleotide similarity (99.9%), three-219 
dimensional protein structures were simulated for F and HN proteins of MF437286 isolate 220 
alone. Compared to vaccine strain (LaSota; AF077761), significant substitutions in signal 221 
  
peptide region and cleavage site of F protein were identified. These include N145K and S176A 222 
in hydrophobic heptad repeat region a (HRa), four in the major trans-membrane domain and 223 
two in cytoplasmic tail (Fig. 4A). Similarly, for the HN protein, the trans-membrane domain 224 
contained eight residue substitutions, three in HRa region, and one each for antigenic site 2, 12 225 
and 23 (Fig. 4B). 226 
Recombination Analysis 227 
 Complete sequences of both isolates were also compared for possible recombination 228 
events. SimPlot showed similarities at non-coding intergenic regions among selected strains 229 
from Class I and II. Utilizing different approaches for detection of putative recombination 230 
events or breakpoints integrated in SimPlot and RDP software, we found a lack of potential 231 
recombination event for study isolates. 232 
Potential of wild bird origin AAvV 1 to cause infection in experimental chicken 233 
The experimentally challenged and contact chickens showed 100% mortality within 6th day of 234 
post-infection (DPI), highlighting the infectious potential of reported AAvV 1. Wherein, 235 
challenged chickens showed clinical signs from 2nd DPI with death of three chickens. The 236 
clinical infection was aggravated and peaked at 3rd DPI with death of four chickens. After three 237 
days, minor clinical signs were observed in one contact chicken. At the end of 4th DPI, the 238 
remaining challenged chickens also succumbed. After five days, severe clinical presentation of 239 
ND was observed in three contact chickens and all contact birds died at the end of sixth day. 240 
The clinical signs in both isolated infected chickens were observed since 2nd DPI, consisting of 241 
anorexia, depression, green-white diarrhea with foamy presence, nasal and ocular discharge, 242 
open mouth breathing, sneezing and coughing. However, no neurological signs were observed 243 
in challenged chickens. The chickens in the control group remained healthy during the entire 244 
experimental duration. On the post-mortem examination of infected chickens, hemorrhages in 245 
lungs and liver, enlarged liver, congested kidneys, mottled spleen, pinpoint hemorrhages in 246 
  
proventricular glands and edamatous bursa were observed. The histopathological observations 247 
were consistent with aforementioned gross lesions including degeneration in hepatocytes, 248 
venous congestion and infiltration of inflammatory cells in portal card of liver (Fig. 5A). Also, 249 
congestion, hemorrhages with mononuclear inflammatory cells infiltration in sub-mucosa of 250 
lung (Fig. 5B), damaged basal membrane and degeneration in follicles of bursa (Fig. 5C), 251 
infiltration of inflammatory cells and congestion in spleen (Fig. 5D), presence of dead/necrotic 252 
tissue mass, dropout of epithelium and inflammatory cells infiltration in small intestine (Fig. 253 
5E) and mild congestion in brain (Fig. 5F) were observed. Whereas, all collected tissues from 254 
chickens of control group had no apparent histological or pathological changes. 255 
DISCUSSION 256 
We presented the first biological, genetic and evolutionary analysis of two AAvV 1 strains 257 
isolated from asymptomatic green-winged teal from Pakistan. These findings highlight the 258 
potential roles of waterfowl in the epizootology of ND, especially in countries where the 259 
disease remains endemic. Based upon mean infectivity and mean death time, both of the under-260 
study isolates were found virulent (53, 57). The AAvVs are considered velogenic with a MDT 261 
of up to 60 hrs, mesogenic if it is 61- 90 hrs and lentogenic if it is > 90 hrs (52). Both isolates 262 
showed 1.5 ICPI value, which is a typical biological characteristic of virulent AAvV 1 strains. 263 
Whereas, virus showing ICPI lower than 0.7 was considered to be a low virulent strain (52). In 264 
accordance to the pathogenicity assessment and horizontal transmission, the clinical and 265 
histopathological observation indicates velogenic nature of virus and categorized them as 266 
velogenic viscerotropic AAvV 1 (39). These clinico-pathological observations of studied 267 
isolates were similar to previously characterized virulent strains of genotypes VII (39). 268 
Phylogenetic clustering of under-study isolates with viruses from different host-origin showed 269 
an evidence of continuous circulation of genotype VII in Pakistan along with potential inter-270 
species transmission (34, 35, 48, 57). A strong phylogenetic relationship between these isolates 271 
  
and Indonesian strains (HQ697254) originated from poultry, proposes an ancestral link 272 
between these isolates (62). Together, it highlights circulation of virulent nature of circulating 273 
sub-genotype VIIi in multiple avian hosts (3, 48) in disease endemic countries including 274 
Pakistan. The AAvVs of genotype VII are known to be genetically diverse and are associated 275 
with recurrent poultry outbreaks, mainly in the Middle East, Asia (4, 33, 48), Africa and South 276 
America (4, 50). For instance, the intercontinental spread of recently panzootic sub-genotype 277 
VIIi demonstrates global significance and economic importance of these viruses (4). 278 
Maximum homology between isolates reported here and characterized previously from chicken 279 
origin highlights susceptibility of multiple avian species as has been documented earlier (25). 280 
Nucleotide divergence from vaccine strains raises concerns on vaccine efficacy against field 281 
circulating AAvV 1 strains of different genotypes (53). While challenge-protection studies are 282 
warranted, potential divergence in residues may predict concerns on efficacy of vaccine being 283 
used to protect susceptible population (10). Also, genetic divergence among different 284 
genotypes (Table 2) highlights continuous evolutionary nature of APMVs in different 285 
geographic location across the globe (10, 36, 61). Under-study isolates were considered 286 
velogenic with the presence of typical cleavage site in the F protein which is a key molecular 287 
determinant of virulence (40). The predicted residue analysis revealed several conserved 288 
neutralising sites (31) that are considered significant for emergence of escape variants. The 289 
presence of six glycosylation sites indicated high virulent nature of isolates as compared to low 290 
virulent AAvVs (38). Whereas, eleven or twelve conserved cysteine residues in AAvV 1 strains 291 
(46) may plays a vital role to maintain connection between F1 and F2 subunit (30). 292 
Substitutions in different influential regions of F protein can enhance the virulence of a virus 293 
(38). For instance, variations in signal peptide and fusion peptide motifs may hinder viral 294 
envelope-cell membrane fusion activity of the F protein (26, 47, 59). In fact, the signal peptide 295 
of F protein is the most hypervariable region among different sub–genotypes of genotype VII 296 
  
(37). A lack of conserve residue pattern was also observed in hydrophobic heptad-repeat 297 
regions and major transmembrane domains. These domains are usually considered essential for 298 
efficient virus fusion; however potential substitutions may affect protein integrity and 299 
subsequent functional changes (7).  300 
Genomic characterization of HN protein revealed a specific ORF length (571aa) in a pattern 301 
similar to those observed for virulent AAvVs (52, 56). Avirulent strains usually carry an ORF 302 
encoding 577 residues where insertion of six amino acids at the C-terminus can act as motif for 303 
inhibition of HN activity (65). The 13-cysteine residues and four glycosylation sites were found 304 
highly conserved (31). However, inter-genotype comparison revealed few substitutions in 305 
trans-membrane domain, HRa region and at site 2. Such substitutions, particularly in a 306 
structural motif in stalk domain (HRa region) are considered responsible for mediating protein-307 
protein interactions, and are proposed to be responsible for increased virulence (65). Key 308 
receptors, antigenic sites responsible for NA activity and sialic acid binding sites including P1, 309 
P2 and P3 were also conserved among studied isolates (9, 18). Compared to vaccine strain 310 
(LaSota isolate), few substitutions were observed in antigenically important regions of the 311 
protein (11). Noteworthy, substitutions in signal peptide, hydrophobic heptad repeat region, 312 
major transmembrane domain and cytoplasmic tail may result in escape mutants owing to the 313 
involvement in structural transition of protein from metastable to stable form (11). These are 314 
in accordance with a previous investigation, where conformational variations in linear epitopes 315 
of HN protein may influence the binding sites for monoclonal antibodies (12) subsequent to 316 
escape mutant. Moreover, substitutions in each site 2, 12 and 23 may affect NA activity, 317 
receptor binding ability and cell fusion of protein suggestive to cause infection (53). 318 
 While analysing of putative recombination events among investigated isolates, we observed 319 
potent inter- and intra-genotypes resemblances in coding and non-coding regions (19, 58). 320 
SimPlot revealed maximum similarity for genotype VII whereas a maximum divergence was 321 
  
observed for vaccine isolates in accordance to previous study (45). Due to lack of significance 322 
for non-coding regions, we analysed only coding regions of studied and other representative 323 
isolates originating from multiple avian species for subsequent identification of breakpoints. 324 
GARD analysis revealed putative recombination events at two positions; one breakpoint at 325 
3811 nt (p = 0.046, AIC score = 76.68) and the other one at 7789 nt (p = 0.0016, AIC score = 326 
4.19). However, these outcomes were not consistent with other tools for detection of 327 
recombination event such as RDP and, therefore could not be considered as recombinant. The 328 
findings are in consistent with observations made previously by Diel et al. (14) who concluded 329 
absolute lack of significance of such recombination events. Though occurrence of natural 330 
recombination may help in emergence of a novel/new mutant virus (22, 41, 45, 57, 64, 66), an 331 
absent or rare occurrence of recombination events has been documented for negative-sense 332 
RNA viruses (23). Taken together, the influence of natural occurrence of recombination in 333 
AAvV 1 evolution is not well documented and remain largely debatable (1, 51). 334 
CONCLUSIONS 335 
 We sequenced and characterized two virulent AAvV 1 strains isolated from clinically 336 
healthy teal. Biological characterization confirmed the F protein cleavage-based virulence of 337 
both isolates, and phylogenetically clustered them within sub-genotype VIIi in genotype VII. 338 
Both showed significant residue substitutions at different sites that are considered important 339 
for virulence and pathogenicity. The finding of current study highlights the potential 340 
transmission of wild bird origin AAvV 1 in commercial poultry. Therefore continuous 341 
monitoring and surveillance of asymptomatic natural reservoirs particularly in disease endemic 342 
regions across the globe are warranted. 343 
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FIGURE LEGENDS: 551 
Fig. 1. The phylogenetic analysis of the studied and previously characterized AAvV 1 552 
strains. The neighbour-joining method with 1000 bootstraps was used for analysis of 553 
evolutionary relationship between study isolates (marked with black circles) and representative 554 
isolates using MEGA 6 software. (A) The phylogenetic analysis was conducted based on the 555 
whole genome, (B) HN gene (C) F gene and (D) hypervariable region of the F gene. 556 
Fig. 2. For observation of substitutions, the inferred amino acid of complete F gene of studied 557 
isolates was compared with AAvV strains from different genotypes (I-XVIII) including 558 
vaccine strains within Class II. Conserved regions are highlighted with red colour, and 559 
structurally and functionally importance residues were labelled. 560 
Fig. 3. The inferred amino acids of complete HN gene of studied isolates were compared with 561 
AAvV strains from different genotypes (I- XVIII) including the vaccine strains within Class 562 
II. Conserved regions are highlighted with red colour. Structurally and functionally importance 563 
residues were labelled. 564 
  
Fig. 4. Structural features of head, neck, and stalk regions of AAvVs 1 F (A) and HN (B) 565 
proteins. Substitutions compared to LaSota strain are highlighted. 566 
Fig. 5. Microscopic examination of histopathological changes at different resolution in 567 
different tissue collected from chickens infected with the Anas carolinensis-I-UVAS-Pak-2015 568 
isolate. Arrows indicate histological and pathological lesions in liver at 40x (A), lung at 10x 569 
(B), bursa at 10x (C), spleen at 40x (D), small intestine at 40x (E) and brain at 40x (F). 570 
  571 
  
Table 1 Epidemiological, genetic and biological characteristics of reported isolates 572 















Anas carolinensis-I-UVAS-Pak-2015 Pakistan 2015 
Green-winged 
teal 
Male CS, OS vvNDV 1:512 + 10-6.51 1.5 49.2 112RRQKR↓F117 VIIi 15,192 nt MF437286 
Anas carolinensis-II-UVAS-Pak-2015 Pakistan 2015 
Green-winged 
teal 
Female CS, OS vvNDV 1:512 + 10-6.53 1.5 50 112RRQKR↓F117 VIIi 15,192 nt MF437287 
a: Mean Death Time in hours (Note: According OIE standard < 60 hours of MDT indicated the velogenic NDV whereas MDT between 60-90 and > than 90 573 
hours represented the mesogenic and lentogenic NDVs, respectively), b: Cleavage site pattern, CS: Cloacal Swabs, OS: Oropharyngeal Swabs, vvNDV: 574 
Viscerotropic velogenic Newcastle disease virus, nt: Nucleotide 575 
 576 





































































































































































































































nt/aa nt/aa nt/aa nt/aa nt/aa nt/aa nt/aa nt/aa nt/aa nt/aa nt/aa nt/aa nt/aa nt/aa nt/aa nt/aa nt/aa nt/aa nt/aa nt/aa nt/aa nt/aa 
Whole 
Genome 
15,192 5064 16.5 16.5 19.3 19.3 16.1 16.1 13.9 14 13.9 13.9 11.8 11.8 1 1 14 14 16.3 16.3 18 18 19.4 19.5 












































































































































































































































































a: Including stop codon, b: exclusive of stop codon, *Vaccine strain LaSota and Mukteswer (Note: Both study isolates have 15,192 genome lengths, 122-578 
15001 is coding region and remaining is non-coding region including, Leader, 3ʹUTR, Intragenic regions, 5ʹUTR and Trailer) 579 
